MIT BE Spinout Companies Take on Covid-19
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic. Learn More
MIT’s Response to the Challenge of Covid-19
MIT is tracking the Covid-19 (coronavirus) situation daily, offering ongoing updates and guidance. This website offers the latest updates and information on what we’re doing. This guidance may change quickly as new information becomes available. Learn More
MIT News: Prof James Collins
Collins Lab used a machine-learning algorithm to identify a drug called halicin that kills many strains of bacteria. Halicin (top row) prevented the development of antibiotic resistance in E. coli, while ciprofloxacin (bottom row) did not. Learn More
MIT News: Prof Linda Griffith
Griffith Lab have created a multitissue model that lets them study the relationships between different organs and the immune system, on a specialized microfluidic platform seeded with human cells. Learn More
MIT News: Prof Peter So
So Lab sensor can measure blood glucose levels non-invasively by shining near-infrared light through the skin and measuring the chemical composition of the tissue below. Learn More
NIH Director's Blog: Prof Katharina Ribbeck
Dr. Francis Collins posts how Ribbeck Lab are out to gain a greater understanding of the biology of healthy mucus—and use that knowledge to develop new therapeutics. Learn More